Supermarket Aisle Displays Draw Regulatory Attention

When pushing your shopping cart down supermarket aisles, have you ever noticed those eye-catching displays of infant formula at the end of shelves? While these promotional setups might seem convenient, public health experts warn they represent a subtle erosion of breastfeeding support systems—and may even violate international standards and national laws.

The International Code of Marketing of Breastmilk Substitutes (Article 5.3) explicitly prohibits any retail-level promotional tactics designed to directly induce purchases. This ban extends beyond free samples and coupons to specifically forbid "special displays" of breastmilk substitutes—a category that includes infant formula, follow-up formula, toddler milk, and feeding bottles with teats.

Subsequent World Health Assembly resolutions have reinforced that no marketing of breastmilk substitutes should compromise breastfeeding. End-cap displays fundamentally serve as visual sales boosters, constituting precisely the type of "inducement" that international agreements aim to prevent.

British law takes a more targeted approach. Current regulations (Article 23) prohibit both advertising and "special displays" designed to promote infant formula sales in retail environments.

While UK rules don't explicitly cover other breastmilk substitutes as broadly as international standards, Department of Health guidelines clearly state that infant formula and follow-on formula shouldn't be displayed together. In practice, manufacturers often circumvent this by using nearly identical packaging across product lines. Major retailer Boots previously defended mixed displays as "operational errors," though the underlying strategy clearly leveraged visual marketing to boost high-margin product sales.

Formula isn't just another grocery item—it's a premium-priced specialty product. Companies pay substantial slotting fees for prime end-cap placements, costs ultimately passed to consumers. Compliance with marketing rules would not only reduce promotional expenses but could stabilize formula pricing by returning products to standard shelf locations.

More concerning is how "just in case" marketing influences maternal decisions. UK surveys show most mothers want to breastfeed longer, but commercial strategies exploit parenting anxieties through relentless visual exposure—gradually eroding confidence in breastfeeding.

While no major lawsuits have emerged, regulatory awareness is growing. Nestlé's controversial clearance sales using illegal end-cap promotions marked a turning point in industry scrutiny. Competitors like Danone have faced similar criticisms.

Advocates emphasize that retailers can maintain formula availability without special displays. Ongoing monitoring aims to ensure marketing practices no longer undermine breastfeeding choices.